Xiankui Tan

Title: Innovations in Immunotherapy by Xiankui Tan

Introduction

Xiankui Tan, an inventive mind from Zhejiang, China, has made significant contributions to the field of immunotherapy with his novel approaches to cancer treatment. His expertise is exemplified through his sole patent, which integrates revolutionary concepts in therapeutic agents utilizing nucleic acids and modified immune cells.

Latest Patents

Tan's patent, titled "Therapeutic agents comprising nucleic acids and TCR modified immune cells and uses thereof," details a groundbreaking therapeutic agent composed of a unique combination of a nucleic acid and a T-cell receptor (TCR) modified immune cell. This innovative therapeutic agent features a first composition containing a nucleic acid that encodes a labeling polypeptide designed for introduction into tumor or cancer cells. The labeled polypeptide carries one or more epitope polypeptides capable of being presented on the surfaces of these cells by MHC class I molecules. The second composition comprises a T cell receptor modified immune cell that specifically recognizes and binds to the presented epitope polypeptide. This synergy between the compositions achieves a significant therapeutic effect, offering novel pathways in tumor treatment.

Career Highlights

Throughout his career, Xiankui Tan has collaborated with notable companies, including Hangzhou Converd Co., Ltd. His work has placed him at the forefront of immunological research and innovations that directly influence cancer therapies.

Collaborations

Tan has worked alongside esteemed colleagues, including Fang Hu and Yafei Hou. Together, they have advanced the understanding of therapeutic interventions in oncology, contributing to the development of effective treatment modalities.

Conclusion

Xiankui Tan exemplifies the role of inventors in the continuous battle against cancer through innovative therapeutic agents. His contributions, particularly his patent involving TCR modified immune cells, mark a notable stride in the field of immunotherapy, promising enhanced outcomes for patients suffering from tumors. As the landscape of cancer treatment evolves, the work of inventors like Xiankui Tan will undoubtedly play a pivotal role in shaping its future.